Moderna’s combo vax against flu, Covid shows promise
Moderna on Thursday announced positive interim results from the Phase 1/2 trial of its investigational combination vaccine against influenza and Covid-19.
Moderna on Thursday announced positive interim results from the Phase 1/2 trial of its investigational combination vaccine against influenza and Covid-19.
Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2
After a month, 13.9 percent of the patients on remdesivir had died compared to 12.8 percent of those in the control group.
Plasma therapy is meant for only those coronavirus patients who are on ventilator support and are critical.
